• Recommendations to others. What do you mean by qualitative nature and how are you going to analyze this? • There is no discussion and conclusion but I do not know whether this is necessary for a protocol?
• How did you translate the SCREENIVF? How did you develop the evaluation questionnaire? Are they validated?
• What about a process evaluation during the RCT? You choose to evaluate the intervention one month after the waiting period. The result of the treatment could influence (being pregnant or not) the results.
REVIEWER
Valentina Lucia La Rosa University of Catania REVIEW RETURNED 27-Sep-2018
GENERAL COMMENTS
I was pleased to review the Manuscript titled "Smartphonesupported Positive Adjustment Coping Intervention (PACI) in case of involuntary childlessness -A randomized controlled trial" (bmjopen-2018-025288) .
It is an interesting paper about the effectiveness of a smartphonesupported psychological intervention for couples undergoing fertility treatment. The study is well written, has important clinical message, and should be of great interest to the readers of BMJ Open. The topic of this study is novel, so it may be of interest for the readers. The Manuscript can be further expanded and improved, and reference list can be updated by citing recent studies about the topic.
According to my opinion, only a few small improvements are needed, as suggested below: -Proof-reading by native English speaker is mandatory, in order to improve readability and correct several typos.
-I suggest further improving reference list about psychological impact of infertility, mentioning some recent studies about this topic: J Psychosom Obstet Gynaecol. intervention for people with "involuntary childlessness" undergoing IVF. I have therefore focused only on the design and proposed analyses for the study, and leave the context-specific content review to experts in this field.
As someone working outside of the field of assisted reproductive technology, my first impression of the paper based on the title was that it was a completely different type of trial. The term "involuntary childlessness" suggests to me that the study focuses on people who have ceased attempting to have children, or cannot due to medical reasons (e.g., hysterectomy). The term "protocol" should also be added to the title. I suggest that the title be reworded so that it is not potentially misleading (e.g., "Smartphone-supported Positive Adjustment Coping Intervention (PACI) for couples undergoing fertility treatment -A randomized controlled trial protocol"). I also have some concerns and suggestions about the design of the trial and the proposed analyses that should be addressed in a revision, and in the conduct of the trial if possible. Design • Is this trial seeking to prevent distress or reduce it? There are no a-priori hypotheses outlining exactly what the intervention expects to find, but this is very important in setting the expectations for the treatment groups. Why do an RCT if there is no hypothesis and you only want to understand "effectiveness"? Moreover, the objectives actually describe the secondary outcomes (perceived effectiveness) rather than the primary outcome of actual effectiveness.
• There is one comment in the article summary dot points stating that there is no routine care group due to ethical reasons, and this is not mentioned or justified in the protocol at all. In my opinion, this RCT will not tell us directly whether either intervention is more beneficial to patients than usual care, so it is critical that this is given further attention.
• The authors state that the design of the intervention/program is based on programs developed in other projects. Please provide citations for those projects.
• The introduction talks about the need to screen for risk of maladjustment. Why bother mentioning this if the present study does not use screening/risk criteria as an inclusion criterion, and they do not mention a secondary goal to examine which risk criteria are associated with a better treatment response.
• I was curious why someone whose cycle failed or a cancelled embryo transfer would result in participant exclusion. Surely this group are at the greatest risk of distress? Please justify this in the protocol.
• The statistician is responsible for participant randomisation and therefore is not blinded. What is the reasoning behind this decision? This introduces a risk of bias into the study design.
• The study does not collect pre-intervention expectations about treatment effectiveness, which is fairly routine in RCTs. Why is this not being measured?
• Why aren't concurrent psychosocial/medical treatments or interventions recorded in the trial?
• There is no mention that participants will be asked about "adverse events". This should be done in such a remote trial given that in some instances people may not respond well to psychosocial interventions without access to one-to-one support (e.g., psychological debriefing has been shown to be more harmful than doing nothing at all after traumatic events).
• The study "information document" indicates that people can withdraw consent at any time without giving reasons. While this is an important design feature ethically, surely where possible there are attempts to collect this information given that this has important implications for the acceptability of the treatment.
• How will compliance/exposure be quantified?
Analyses
• While I have recorded that the analytic approach is appropriate, I believe that there are better ways that the interventions could be analysed.
• The power is calculated based on a simple factorial ANOVA, but the authors expect to find that some individual differences between participants (e.g., pregnancy status) will moderate the effects.
What is the required sample if including moderators or interaction effects? The proposed analyses do not describe whether/how they will adjust for baseline differences in distress, or how they will handle missing data. It would be much more appropriate to use mixed linear modelling with covariates, especially if there is likely to be missing follow up data. Further information on just how the power calculation was performed is needed -what program was used?
• Will the analyses be conducted in accordance with an intention to treat approach?
• Will the authors specifically examine acceptability with respect to the ratio of participants completing each intervention?
Minor
• Make sure that the formatting is consistent. At one point the font style and size changed (Page 9). 3. "In our study, we use this kind of cognitive distraction in a much less specific form as a comparison intervention designed to mildly distract the patients during the waiting period." The rationale of the control group condition is not 100% clear to the reader. The authors should provide a rationale for the why on "much less specific form" Why and what is meant with it in more detail?
REVIEWER
4. The terms "perceived effectiveness and practicability of the intervention" are used in the goal section while the terms "information on feasibility and on participant satisfaction" are used in the abstract. Again, in the intro section it is called "satisfaction with the entire treatment process". In the section "Evaluation questionnaire" constructs such as "word-ofmouth/recommendation to others" are added which adds another aspect. It is thus recommended that the authors use the very same terminology throughout the paper to make the secondary outcomes and their measures concise and consistent throughout the study protocol. 6. Sample Size: The authors should provide a rationale / justificatory knowledge / details why a medium effect size is assumed (e.g. by referencing related work that conducted similar research). It is not clear how this effect size relates to the active control group. If it is assumed that the active control group has only a small effect size (is that true or is even a medium effect size hypothesised as well), then a corresponding rationale should be provided by the authors why a medium effect size is chosen.
I wish the authors the best of luck for this important research.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Reviewer Name: Hetty Ockhuijsen
We would like to thank Reviewer # 1 for her valuable comments and helpful advice.
Dear authors, interesting study and interesting research protocol. Thank you for giving me the opportunity to review this protocol. Below feedback to improve the article:
1. A clear research questions according the PICO is missing. You choose for the SCREENIVF as a primary outcome but SCREENIVF measures 5 variables. What is the primary outcome of those five? -Thank you for this important comment and question. With our study, we aim to respond to PICO question 3C from the ESHRE Guideline Psychology (2012) "How should the psychosocial needs of couples during fertility treatment be addressed?" Though the PICO questions aren't that familiar to every reader, we resigned to point this question out in the article. However, we now tried to make the PICO question more clearly in the manuscript in the introduction. We choose the ScreenIVF as primary outcome as it is a validated tool and by grounds of its comprehensive collection of psychosocial burden during fertility treatment. As pointed out above, we want to use the ScreenIVF as progression tool and not as a predictive tool. Primary outcome will be changes in all five scales. We adjusted our manuscript to highlight this fact.
2. Abstract is not complete and not always clearly written. For instance about the primary outcome.
-Thank you for this noteworthy remark. You are right; we altered the abstract and specified the primary outcome.
3. Introduction is clearly written but not always the latest references are used. For instance new information is available about the SCREENIVF, PRCI studies. . -Thank you for this helpful advice. You were absolutely right. We made a thorough literature research and added the latest literature about E-Therapy (1 study), SCREENIVF (2 studies) and PRCI (3 studies).
4. The original PRCI has been validated in different population's waiting for different reasons. The statements of your intervention are different. How did you developed and validated this adapted tool? -Thank you for these important questions. First, we translated the original PRCI statements in German (with approval from Prof. Jacky Boivin). Second, we transformed them into more active phrases, with the words "I shall" or "I will" instead of starting with a verb ("Try to see things positively". "Look on the bright side of life"). We made this transformation to enhance patients feeling of control and capability of the situation with the active "I shall" or "I will". Feedback from other German researches supported these changes. Third, since we started the text messages on the day of oocyte puncture/thawing, we had thirteen days, but just ten original statements. Since we didn't want to send three sentences twice, we had to develop three new sentences. We based the three sentences on literature of basic German cognitive behavioural therapy (e.g. Linden, & Hautzinger (Ed.), Verhaltenstherapiemanual, Springer, Berlin 2008 or Kanfer, Reinecker, & Schmelzer, Selbstmanagement-Therapie: Ein Lehrbuch für die klinische Praxis. Springer, Berlin/ New York 2012). Several researchers from different professions (including psychotherapists) were involved in modifying and developing the statements.
5. Information about the other intervention, cognitive distraction, is limited. Also the rational for using this intervention instead of a control group with standardized care is not clearly written.
-Thank you for this insightful comment. You are totally right, our focus was the PACI intervention and thus we highlighted this intervention more than the control intervention. We adjusted the corresponding section in the introduction and stressed your important remark. Also we added information about our rationale for using this intervention instead of a routine care group. We had no routine care group due to methodological and practicability reasons. The methodological reason included the risk of patient talks in the waiting room. We didn't want patients to hear from other couples that others are getting text messages, when they got nothing. We thought about installing a waiting-list control group; however this was not possible due to practicability reasons at the clinic (resources of clinic staff). Though, we assume the cognitive distraction intervention to be less effective than the PACI intervention and thus, according to the original PRCI-study (PRCI vs. PMI; Lancastle & Boivin, 2008) , view the study as a comparison between two interventions.
6. The structure of the article needs some changes. For instance in the section about the objective you also write about the process of the study. Avoid repetition of information.
-Thank you for your significant suggestion. You are absolutely right; we altered the corresponding section and screened the manuscript for other repetitions.
7. Both men and women are participating in the study. Very good to involve men but there is no information in the introduction.
-Thank you for your valuable advice. You are totally right; we altered the introduction to strengthen this fact.
8. Some information needs specification. For instance on what day of the waiting period was the randomization? -Thank you for this important question. We altered the corresponding section to make the randomization process more clear. Randomization took always place on the day of oocyte puncture/thawing, thus in our Flowchart on Day 0. We defined the waiting period as time from oocyte puncture/thawing to pregnancy test and not only embryo transfer to pregnancy test, since waiting for a fertilization result or thawing result counted for us as waiting period. Furthermore, in this way it was the same waiting period for all couples, independent of specialized treatment options like transfer of blastocytes, in-vitro-maturation etc. We altered the corresponding section to make the randomization process more clear.
9. Information about the analysis is limited.
-Thank you for these insightful questions. 11. There is no discussion and conclusion but I do not know whether this is necessary for a protocol? -Thank you for this comment. Regarding the guidelines of BMJ open, discussion and conclusion are not necessary for a study protocol; in other journals those sections may be required for a study protocol.
12. How did you translate the SCREENIVF? -Thank you for this insightful request. We adopted the valid German translations from the BDI-II and STAI; the other two questionnaires from the ScreenIVF were translated in German by us and then translated back by a Native Speaker. The reverse translation was in almost perfect agreement and we made only minor changes.
13. How did you develop the evaluation questionnaire? Are they validated? -Thank you for these important questions. We adapted the intervention evaluation form (IEF) from Lancastle & Boivin (2008) and reduced the 23-item questionnaire (practicality, acceptability, endorsement and feasibility, perceived psychological effects and perceived duration of intervention effects) to 4 items (perception of the time involved, the efficacy and the practicability of the intervention techniques, recommendation to others). We reduced the IEF to 4 items due to better manageability for smartphone entry's and higher response rate.
14. What about a process evaluation during the RCT? You choose to evaluate the intervention one month after the waiting period. The result of the treatment could influence (being pregnant or not) the results.
-Thank you for this noteworthy comment. We ask the participants at T2 if they have already tested for pregnancy and in T3, if they are pregnant at the moment. Furthermore, if the participants made their pregnancy test in the fertility clinic, we will be informed about the result. In every case, pregnancy status will be included in all analyses as moderator variable.
Reviewer: 2 Reviewer Name: Valentina Lucia La Rosa
We would like to thank Reviewer # 2 for her noteworthy remarks and helpful advice.
It is an interesting paper about the effectiveness of a smartphone-supported psychological intervention for couples undergoing fertility treatment. The study is well written, has important clinical message, and should be of great interest to the readers of BMJ Open. The topic of this study is novel, so it may be of interest for the readers. The Manuscript can be further expanded and improved, and reference list can be updated by citing recent studies about the topic.
According to my opinion, only a few small improvements are needed, as suggested below: 1. Proof-reading by native English speaker is mandatory, in order to improve readability and correct several typos.
-Thank you for this valuable advice. We agree with you and will give the manuscript to a native speaker before re-submission. Reviewer: 3 Reviewer Name: Melita Giummarra
We would like to thank Reviewer # 3 for her valuable remarks and noteworthy advice.
I have been invited to provide a methodological review of this manuscript, which describes a protocol for a RCT that is currently underway. The study is evaluating a smartphone-supported intervention for people with "involuntary childlessness" undergoing IVF. I have therefore focused only on the design and proposed analyses for the study, and leave the context-specific content review to experts in this field. 1. As someone working outside of the field of assisted reproductive technology, my first impression of the paper based on the title was that it was a completely different type of trial. The term "involuntary childlessness" suggests to me that the study focuses on people who have ceased attempting to have children, or cannot due to medical reasons (e.g., hysterectomy). The term "protocol" should also be added to the title. I suggest that the title be reworded so that it is not potentially misleading (e.g., "Smartphone-supported Positive Adjustment Coping Intervention (PACI) for couples undergoing fertility treatment -A randomized controlled trial protocol").
-Thank you for this valuable advice. We adjusted our title according to your proposal.
I also have some concerns and suggestions about the design of the trial and the proposed analyses that should be addressed in a revision, and in the conduct of the trial if possible. Design 2. Is this trial seeking to prevent distress or reduce it? -Thank you for this important question. The trial is seeking to reduce stress; we revised our manuscript, especially the description of our primary outcome, to highlight this fact.
3. There are no a-priori hypotheses outlining exactly what the intervention expects to find, but this is very important in setting the expectations for the treatment groups. Why do an RCT if there is no hypothesis and you only want to understand "effectiveness"? -Thank you for this noteworthy remark. You are right and we inserted our exploratory hypothesis in the objective paragraph. We expect the PACI intervention to be more effective in reducing psychosocial burden compared to the cognitive distraction intervention.
4. Moreover, the objectives actually describe the secondary outcomes (perceived effectiveness) rather than the primary outcome of actual effectiveness.
-Thank you for this significant comment. You are totally right, we altered our objectives section to explicit describe our primary and our secondary outcomes.
5. There is one comment in the article summary dot points stating that there is no routine care group due to ethical reasons, and this is not mentioned or justified in the protocol at all. In my opinion, this RCT will not tell us directly whether either intervention is more beneficial to patients than usual care, so it is critical that this is given further attention.
-Thank you for this major remark. You are totally right, this is an important point. We adjusted the article summary dot point and also assessed this point in the introduction section. We had no routine care group due to methodological and practicability reasons. The methodological reason included the risk of patient talks in the waiting room. We didn't want patients to hear from other couples that they are getting text messages, when they got nothing. We thought about installing a waiting-list control group; however this was not possible due to practicability reasons at the clinic (resources of clinic staff). Though, we assume the cognitive distraction intervention to be less effective than the PACI intervention and thus, according to the original PRCI-study (PRCI vs. PMI; Lancastle & Boivin, 2008) , view the study as a comparison between two interventions. Furthermore, having the evaluation questionnaire, we will know if one or even both interventions are rated as beneficial in this waiting period. If both are rated as helpful, we will also be happy. Additional, for most of the participants the particular cycle won't be their first IVF cycle, unfortunately. Thus, they can rate the effectiveness of the waiting period interventions with experience.
6. The authors state that the design of the intervention/program is based on programs developed in other projects. Please provide citations for those projects.
-Thank you for this important request. We revised the section "The Positive Adjustment Coping Intervention during the waiting period" and inserted more literature regarding this topic. Furthermore, we now highlighted the previous interventions in the objective section ("Based on previous research regarding the PRCI-intervention [literature citations],…").
7. The introduction talks about the need to screen for risk of maladjustment. Why bother mentioning this if the present study does not use screening/risk criteria as an inclusion criterion, and they do not mention a secondary goal to examine which risk criteria are associated with a better treatment response.
-Thank you for this insightful suggestion. You are absolutely right and we revised our manuscript regarding the screening of risk factors. Our intervention aims to reduce psychosocial burden and not to screen for risk of maladjustment in terms of in-or exclusion or prediction. Therefore, we now highlighted our primary outcome and our use of the ScreenIVF as progression tool (not screening tool) in this study.
8. I was curious why someone whose cycle failed or a cancelled embryo transfer would result in participant exclusion. Surely this group are at the greatest risk of distress? Please justify this in the protocol.
-Thank you for this valuable remark. You are totally right, the group of people having a cancelled embryo transfer has for sure a great risk of distress. However, the intervention is just for the waiting period between oocyte puncture/thawing and pregnancy test. People who have a cancelled embryo transfer don't have a waiting period, and thus, they can't use this intervention. We inserted a sentence in the manuscript justifying this procedure. Furthermore, we will keep your remark in mind; for sure it would be very important to design a new project caring for those with failed cycles.
9. The statistician is responsible for participant randomisation and therefore is not blinded. What is the reasoning behind this decision? This introduces a risk of bias into the study design.
-Thank you for this noteworthy question. The statistician has to no time contact to the participants and knows nothing about their (former) treatment and/or personal parameters. He will just get the participant codes and the mobile phone numbers. Text messages are send directly and automatically from the Center for Psychotherapy Research and not from the statistician; thus there is no risk of bias.
10. The study does not collect pre-intervention expectations about treatment effectiveness, which is fairly routine in RCTs. Why is this not being measured? -Thank you for this insightful remark. We considered the feasibility study from Lancastle and Boivin (2008) as pre-intervention experience.
11. Why aren't concurrent psychosocial/medical treatments or interventions recorded in the trial? -Thank you for this important request. Record of concurrent psychosocial/medical treatments or interventions is not possible due to practical reasons (e.g. length of questionnaires). However, we record all couples taking the offer for in-house counseling. Furthermore, if patients are having medical treatments/interventions before or during their participation of the study, this will be recorded in their medical file at the fertility clinic and will thus be recorded by us. Additionally we assume that psychosocial/medical treatments or interventions will be distributed similar over the two groups.
12. There is no mention that participants will be asked about "adverse events". This should be done in such a remote trial given that in some instances people may not respond well to psychosocial interventions without access to one-to-one support (e.g., psychological debriefing has been shown to be more harmful than doing nothing at all after traumatic events).
-Thank you for this significant suggestion. According to former studies using similar techniques, we don't expect any adverse events. However, all participants at the clinic are informed about the offer of in-house counseling, which is free of any cost and can be made use of to any time. Furthermore, there is a study mail account (noted on the information leaflet as in every reminding text message) and participants are encouraged in every text message to write us, if they have any questions or concerns. Additional, all participants are informed about the option of withdrawal from the study by their treating physician and in the information leaflet; thereby highlighting the fact that there won't be any disadvantage in terminating the study.
13. The study "information document" indicates that people can withdraw consent at any time without giving reasons. While this is an important design feature ethically, surely where possible there are attempts to collect this information given that this has important implications for the acceptability of the treatment.
-Thank you for this noteworthy request. To every time, participants had the option to withdrawal from the study by telling the treating physician, writing to the study mail account or indicating their withdrawal in the free text option in every questionnaire.
14. How will compliance/exposure be quantified? -Thank you for this insightful comment. There is no direct quantification of compliance/exposure in our study. However, we will quantify the response rate to T2 and T3 as the respective number of reminding text messages for filling in the online questionnaire. Regarding exposure, participants are asked to comment at T3, evaluation questionnaire, on time effort and effectiveness of the intervention.
Analyses
While I have recorded that the analytic approach is appropriate, I believe that there are better ways that the interventions could be analysed.
15. The power is calculated based on a simple factorial ANOVA, but the authors expect to find that some individual differences between participants (e.g., pregnancy status) will moderate the effects.
What is the required sample if including moderators or interaction effects? -Thank you for this significant question. We conducted further sample size analysis with g*power to capture moderator and interaction effects. In all cases, the required sample was close to the numbers in the protocol or even less. Furthermore, the current participant's response rate is much higher than expected; hence we will achieve even a bigger sample size than statistically required.
16. The proposed analyses do not describe whether/how they will adjust for baseline differences in distress, or how they will handle missing data.
-Thank you for this valuable remark. You are totally right, this important information is missing. We adjusted the analysis section and inserted the missing information concerning baseline analysis and handling of missing data.
17. It would be much more appropriate to use mixed linear modelling with covariates, especially if there is likely to be missing follow up data. Further information on just how the power calculation was performed is needed -what program was used? -Thank you for this insightful request. We will keep your suggestion in mind in the event of many missing data. We used the statistical tool G*Power to compute statistical power analyses and effect sizes. We inserted this information now in the section regarding Sample Size.
18. Will the analyses be conducted in accordance with an intention to treat approach? -Thank you for this important question. The analyses are always related to the couples or patients who have started the intervention study (baseline). At each later stage, drop-out analyses will be performed for sociographic, psychological and medical variables, separately for each intervention group.
19. Will the authors specifically examine acceptability with respect to the ratio of participants completing each intervention? -Thank you for this noteworthy question. Yes, as mentioned above, with the respective drop-out analyses at the individual time points, the acceptability of the individual interventions and follow-up evaluation can be adequately assessed.
Minor 20. Make sure that the formatting is consistent. At one point the font style and size changed (Page 9).
-Thank you for this valuable note. You are right; we adjusted the formatting.
Reviewer: 4 Reviewer Name: Tobias Kowatsch
We would like to thank Reviewer # 4 for his significant suggestions and valuable advice. With this study protocol entitled "Smartphone-supported Positive Adjustment Coping Intervention (PACI) in case of involuntary childlessness -A randomised controlled trial", the authors plan to investigate the utility of a Smartphone-supported Positive Adjustment Coping Intervention (for individuals and couples) by comparing it to an active control group which gets distraction messages. The structure of the paper is clear and the paper is written very well. The planned data analyses are appropriate. The following suggestions are provided to improve the clarity of the authors' statements:
1. "The study tests a validated tool in a fully powered randomised controlled trial"? It is not clear to the reader why a fully powered RCT is necessary if the tool is already validated / maybe it is not clear what the authors mean with validated in this context. Is it the German translation and adaptation of the validated PRCI tool which makes the big difference and the study worthwhile? This should be made more concise.
-Thank you for these important questions. We completely agree with you, it is not clear to the reader why testing a validated tool is strength of this study. Thus, we altered the respective statement to "The study tests a validated tool in a fully powered randomized controlled trial, adapted for a German sample", thereby highlighting the fact that is the first application of this tool in Germany.
2. "The study addresses a novel smartphone-supported approach and works with a study population not previously investigated with this tool" >> It is not clear to which the term novel refers to. Smartphone-based text messaging interventions are very common for more than a decade (e.g. in the public health context for smoking cessation interventions). The authors should make clear what the novel aspect is (e.g. the topic per se and not the technology per se) and it should be consistent with the statements in the Objective section ("Based on previous research...") that make the contribution (and the delta to prior research) of this study explicit.
-Thank you for this insightful remark. You are totally right, of course, smartphone-based text messaging is no novel intervention. The term "novel" refers to the fact that in all former PRCI studies, PRCI was always used with paper cards, that is study participants received a leaflet with PRCI statements to read those twice a day. Sending those statements per smartphone is "novel" for this technique. Furthermore, men have never been investigated with this tool. We adjusted the respective statement to "The study addresses the tool in a novel smartphone-supported approach and works with male participants, a study population not previously investigated with this tool", thereby making the strength more clearly.
3. "In our study, we use this kind of cognitive distraction in a much less specific form as a comparison intervention designed to mildly distract the patients during the waiting period." The rationale of the control group condition is not 100% clear to the reader. The authors should provide a rationale for the why on "much less specific form" Why and what is meant with it in more detail? -Thank you for this significant question. As pointed out above, this is a very important point. We adjusted the corresponding section in the introduction and added information about our rationale, why we used this intervention in a "much less specific form" and why we used this intervention instead of a routine care group.
4. The terms "perceived effectiveness and practicability of the intervention" are used in the goal section while the terms "information on feasibility and on participant satisfaction" are used in the abstract. Again, in the intro section it is called "satisfaction with the entire treatment process". In the section "Evaluation questionnaire" constructs such as "word-of-mouth/recommendation to others" are added which adds another aspect. It is thus recommended that the authors use the very same terminology throughout the paper to make the secondary outcomes and their measures concise and consistent throughout the study protocol.
-Thank you for this valuable comment. You are absolutely right. We decided to take on the terminus "perceived effectiveness and practicability of the intervention" and adjusted all secondary outcomes to this terminus. 6. Sample Size: The authors should provide a rationale / justificatory knowledge / details why a medium effect size is assumed (e.g. by referencing related work that conducted similar research). It is not clear how this effect size relates to the active control group. If it is assumed that the active control group has only a small effect size (is that true or is even a medium effect size hypothesised as well), then a corresponding rationale should be provided by the authors why a medium effect size is chosen.
-Thank you for this noteworthy request. We based our assumption regarding a medium effect size for assessing group differences on related work regarding intervention RCTs (Ockhuijsen et al., 2013; Phelps et al., 2013) . Thus, we referenced the corresponding work in our manuscript now.
-Thank you so much for these grateful wishes.
VERSION 2 -REVIEW

REVIEWER
Melita Giummarra Monash University
REVIEW RETURNED
28-Feb-2019
GENERAL COMMENTS
Overall I am pleased with the revisions that the authors have made to their protocol manuscript, and most aspects of the trial are much clearer. There was no response to our reviewer comments submitted (as far as I could tell), but it seems that the authors chose not to address some of my original concerns, particularly:
• How will exposure or compliance be quantified?
• Will the analyses be conducted in accordance with an intention to treat approach? For instance, will the analyses include people who are lost to follow up at one or more assessment times, or if they withdraw further participation but are happy for their data to be used in the study?
Other minor suggestions that the authors should consider in their revision are listed below:
• Revise wording of "due to practicability" (this doesn't make sense to me)
• Provide the clinically meaningful cut scores for the ScreenIVF • Report the cohort on which the Cronbach Alpha was derived (or provide citations)
• Describe the timing of evaluations using consistent terms -the final assessment is described as being 6-weeks after transfer early in the protocol, but as being one month after the pregnancy test in the paragraph before the Data Analysis section. 
REVIEWER
GENERAL COMMENTS
I would like the authors for the revised version of their manuscript entitled "Smartphone-supported Positive Adjustment Coping Intervention (PACI) for couples undergoing fertility treatment -A randomized controlled trial protocol". The authors have addressed the raised issues in the current version of the manuscript.
VERSION 2 -AUTHOR RESPONSE Replies to the reviewers
Dear Reviewers, we would like to take this opportunity to express our sincere thanks for your valuable time and your significant suggestions.
Reviewer: 3
Reviewer Name: Melita Giummarra
We would like to thank Reviewer # 3 for her significant and valuable remarks again.
Overall I am pleased with the revisions that the authors have made to their protocol manuscript, and most aspects of the trial are much clearer.
-> Thank you so much for this feedback.
There was no response to our reviewer comments submitted (as far as I could tell), but it seems that the authors chose not to address some of my original concerns, particularly: -> In our first revision, we addressed all of your original concerns in detail in our letter to the reviewers, especially those which couldn't be addressed in the manuscript directly. We will happily address those concerns again in the following.
1. The statistician is responsible for participant randomisation and therefore is not blinded. What is the reasoning behind this decision? This introduces a risk of bias into the study design.
-> Thank you for this noteworthy question. The statistician has to no time contact to the participants and knows nothing about their (former) treatment and/or personal parameters. He will just get the participant codes and the mobile phone numbers. Text messages are sent directly and automatically from the Center for Psychotherapy Research and not from the statistician; thus there is no risk of bias.
2. The study does not collect pre-intervention expectations about treatment effectiveness, which is fairly routine in RCTs. Why is this not being measured? -> Thank you for this insightful remark. We considered the feasibility study from Lancastle and Boivin (2008) as pre-intervention experience.
3. Why aren't concurrent psychosocial/medical treatments or interventions recorded in the trial? -> Thank you for this important request. Record of concurrent psychosocial/medical treatments or interventions is not possible due to practical reasons (e.g. length of questionnaires). However, we record all couples taking the offer for in-house counseling. Furthermore, if patients are having medical treatments/interventions before or during their participation of the study, this will be recorded in their medical file at the fertility clinic and will thus be recorded by us. Additionally we assume that psychosocial/medical treatments or interventions will be distributed similar over the two groups.
4. There is no mention that participants will be asked about "adverse events". This should be done in such a remote trial given that in some instances people may not respond well to psychosocial interventions without access to one-to-one support (e.g., psychological debriefing has been shown to be more harmful than doing nothing at all after traumatic events).
-> Thank you for this significant suggestion. According to former studies using similar techniques, we don't expect any adverse events. However, all participants at the clinic are informed about the offer of in-house counseling, which is free of any cost and can be made use of to any time. Furthermore, there is a study mail account (noted on the information leaflet as in every reminding text message) and participants are encouraged in every text message to write us, if they have any questions or concerns. Additional, all participants are informed about the option of withdrawal from the study by their treating physician and in the information leaflet; thereby highlighting the fact that there won't be any disadvantage in terminating the study.
5. How will exposure or compliance be quantified? -> Thank you for this insightful comment. There is no direct quantification of compliance/exposure in our study. However, we will quantify the response rate to T2 and T3 as the respective number of reminding text messages for filling in the online questionnaire. Regarding exposure, participants are asked to comment at T3, evaluation questionnaire, on time effort and effectiveness of the intervention. 6. Will the analyses be conducted in accordance with an intention to treat approach? For instance, will the analyses include people who are lost to follow up at one or more assessment times, or if they withdraw further participation but are happy for their data to be used in the study? -> Thank you for this important question. The analyses are always related to the couples or patients who have started the intervention study (baseline). At each later stage, drop-out analyses will be performed for sociographic, psychological and medical variables, separately for each intervention group.
7. Will the authors specifically examine acceptability with respect to the ratio of participants completing each intervention? -> Thank you for this noteworthy question. Yes, as mentioned above, with the respective drop-out analyses at the individual time points, the acceptability of the individual interventions and follow-up evaluation can be adequately assessed.
8. Revise wording of "due to practicability" (this doesn't make sense to me) -> Thank you this insightful advice. We revised the wording to "for organizational".
9. Provide the clinically meaningful cut scores for the ScreenIVF -> Thank you for this significant suggestion. We now provided the clinically meaningful cut-off scores in our manuscript.
10. Report the cohort on which the Cronbach Alpha was derived (or provide citations) -> Thank you for this important remark. We now provided a citation for the Cronbach Alphas in our manuscript.
11. Describe the timing of evaluations using consistent terms -the final assessment is described as being 6-weeks after transfer early in the protocol, but as being one month after the pregnancy test in the paragraph before the Data Analysis section.
-> Thank you for this noteworthy advice. You are totally right, we changed all terms describing the timing of evaluation to "one month after the waiting period".
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